← SynDRA
MOEXIPRIL
SynDRA canonical compound SYN0004210 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ACE |
|---|
| Mechanism of action | Angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- moexipril hydrochloride
- moclobenid
- moexipril HCl
- Uniretic
- RS-10085
- Moexiprilum
- Moexipril (INN)
- Moexipril [INN:BAN]
- Moexiprilum [INN-Latin]
- Perdix (TN)
- Univasc (TN)
- (3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
- (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
- WT87C52TJZ
- Moex
- RefChem:819096
- DTXCID803330
- C09AA13
- MOEXIPRIL [INN]
- UNII-WT87C52TJZ
- MOEXIPRIL [MI]
- MOEXIPRIL [VANDF]
- MOEXIPRIL [WHO-DD]
- SCHEMBL34030
- BIDD:GT0007
- CHEBI:6960
- GTPL6571
- orb1686666
- SCHEMBL29376544
- UWWDHYUMIORJTA-HSQYWUDLSA-N
- BDBM50084673
- EBC-27236
- EX-A12329
- AKOS015843317
- NCGC00263546-03
- HY-117281
- CS-0064930
- NS00006495
Reported adverse events
- Angioedema
- Cough
- Dizziness
- Fatigue
- Flushing
- Myalgia
- Pharyngitis
- Rash
- Abdominal pain
- Bronchospasm
Look up MOEXIPRIL in the interactive SynDRA portal →